TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
5.72
-0.01 (-0.17%)
Apr 28, 2025, 4:00 PM EDT - Market closed

TriSalus Life Sciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
185153222313309-
Market Cap Growth
-31.30%-31.30%-29.05%1.52%--
Enterprise Value
200165203351--
Last Close Price
5.725.018.4510.039.88-
PS Ratio
4.925.1912.0125.2836.75-
PB Ratio
-7.13-5.90-8.22-25.439.99-
EV/Sales Ratio
6.795.6010.9528.32--
Debt / Equity Ratio
-0.91-0.91-0.06-0.16--0.84
Asset Turnover
1.211.210.800.410.37-
Inventory Turnover
1.251.251.301.631.28-
Quick Ratio
1.331.331.040.344.970.09
Current Ratio
2.022.021.420.535.510.11
Return on Equity (ROE)
----507.96%--
Return on Assets (ROA)
-93.08%-93.08%-134.61%-76.13%-65.35%-
Return on Capital (ROIC)
----221.74%-131.01%-
Earnings Yield
-18.00%-19.67%-26.70%-15.05%-9.34%-
FCF Yield
-22.31%-26.96%-23.01%-10.52%-7.71%-
Buyback Yield / Dilution
-169.61%-169.61%-2934.71%96.51%-15.52%-
Updated Mar 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q